KRISTIE MCCANN: Open Payments
NPI 1679137392 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 24 payments from 12 companies in 2025. Trend: 2023 $826 · 2024 $378 · 2025 $772
Food & beverage: $480Education: $292
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $194 |
| Lilly USA, LLC | 2 | $138 |
| Regeneron Healthcare Solutions, Inc. | 6 | $137 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $136 |
| ABBVIE INC. | 2 | $29 |
| UCB, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: TREMFYA, DUPIXENT, EBGLYSS, ILUMYA, Bimzelx, OPZELURA, CIBINQO, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
